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Fibromyalgia (FM) is a generalized chronic pain condition associated with a variety of
symptoms, including altered cognitive and emotional processing. It has been proposed
that FM patients show a preferential allocation of attention to information related to
the symptoms of the disease, particularly to pain cues. However, the existing literature
does not provide conclusive evidence on the presence of this attentional bias, and
its effect on cognitive functions such as inhibitory control. To clarify this issue, we
recorded the electroencephalographic activity of 31 women diagnosed with FM and
28 healthy women, while performing an emotional Go/NoGo task with micro-videos of
pain, happy, and neutral facial expressions. We analyzed behavioral data, performed
EEG time-frequency analyses, and obtained the event-related potentials (ERPs) N2
and P3 components in NoGo trials. A series of self-reports was also administered to
evaluate catastrophic thinking and the main symptoms of fibromyalgia. Pain expressions
were associated with longer reaction times and more errors, as well as with higher
theta and delta power, and P3 amplitude to NoGo stimuli. Thus, behavioral and
psychophysiological data suggest that increased attention to pain expressions impairs
the performance of an inhibitory task, although this effect was similar in FM patients and
healthy controls. N2 amplitude was modulated by type of facial expression (larger to
pain faces), but only for the control group. This finding suggests that the presentation of
pain faces might represent a smaller conflict for the patients, more used to encounter
pain stimuli. No main group effects were found significant for N2 or P3 amplitudes, nor
for time-frequency data. Using stimuli with greater ecological validity than in previous
studies, we could not confirm a greater effect of attentional bias toward negative stimuli
over inhibitory performance in patients with FM. Studying these effects allow us to better
understand the mechanisms that maintain pain and develop intervention strategies to
modify them.
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INTRODUCTION
Fibromyalgia (FM) is a chronic pain condition of
unknown etiology, characterized by the presence of generalized
musculoskeletal pain, in addition to fatigue, poor sleep quality,
anxiety, depression, and altered cognitive and emotional
processing. It has been proposed that FM patients show a
preferential allocation of attention to information related to the
symptoms of the disease, particularly to pain cues. This idea
has been discussed as hypervigilance and, more recently, as
attentional bias (AB) (Crombez et al., 2013).
Attention toward nociceptive stimulation is believed to
modulate the painful experience. Some studies have shown that
focusing attention on noxious stimuli made them be perceived
as more intense and more unpleasant than directing attention
elsewhere (Garcia-Larrea and Jackson, 2016). Even observing
empathically other people’s pain can enhance our own intensity
reports to painful stimuli (deWied and Verbaten, 2001; Godinho
et al., 2008). Therefore, the investigation of AB to pain-related
information may help to understand the causal mechanisms of
pain maintenance as well as the development of anxiety and
depression associated to pain (Aldrich et al., 2000; Crombez et al.,
2012).
Although patients with chronic pain are often thought to be
characterized by hypervigilance toward pain-related information
(Pearce and Morley, 1989), this assumption is controversial.
Many studies have failed to replicate this result, either reporting
no evidence of such bias (Pincus et al., 1998; Asmundson et al.,
2005), or finding similar biases in patients, and healthy controls
(Crombez et al., 2000; Snider et al., 2000; Beck et al., 2001;
Andersson and Haldrup, 2003). In their 2013 review, Crombez
et al. concluded that there is a bias toward pain-related words
or images in patients with chronic pain conditions such as
fibromyalgia. They added, however, that the effect is small, and
that AB toward signals of pain was present in healthy participants
as well. Therefore, it is not a robust phenomenon, nor is it easy to
identify, generate or replicate (Crombez et al., 2013).
Several factors may explain the inconsistent pattern of
evidence concerning AB in patients with chronic pain. Among
them, the lack of ecological validity of stimuli (usually pain-
related words),—that may not represent the patients’ real
concerns or may not be relevant to the population studied—, and
the exposure time of stimuli have been underscored as critical
variables (Crombez et al., 2013). In spite of the greatest potential
impact of using images, their inclusion in studies investigating
AB is rather recent and limited. Also, most of the studies have
only analyzed behavioral indices (that is, reaction times or hit
rates), which may not be sensitive enough to the effect of AB.
To overcome some of the above issues, in this study we
presented dynamic faces with different expressions (pain, neutral,
and happiness) using 500ms micro-videos, and proposed a
different strategy to assess the effect of AB. Our objective was
to investigate how attention toward pain-related information
affects response inhibition, one of the executive functions altered
in fibromyalgia (Correa et al., 2011). Several authors argue
that the neural circuits of inhibitory control and pain may
overlap, and thus that the brain regions engaged in response
inhibition might be hypoactivated in chronic pain patients (Glass
et al., 2011; Schmidt-Wilcke et al., 2014). To clarify this, we
recorded electrophysiological activity and behavioral data during
the performance of a Go/NoGo emotional task from patients
with FM and healthy controls. Due to the dynamic nature of
stimuli, EEG was analyzed by time-frequency decomposition.
Theta and delta activity increases have been observed during
NoGo response inhibition (Harper et al., 2014), although the
effect of the presence of pain on them has not been explored
to date. We also analyzed the N2 and P3 components of the
event-related potentials (ERPs), two indices obtained in NoGo
trials and related to conflict monitoring and response inhibition,
respectively (Zhang and Lu, 2012).
The objectives of the present work were (1) to clarify
whether fibromyalgia patients show higher interference of
attention toward pain stimuli over inhibitory control (using both
behavioral and brain activity indices); (2) to assess whether the
amplitudes of N2 and P3 to painful faces are related to the core
symptoms of fibromyalgia (such as pain severity, catastrophism,
depression, or sleep disturbances). Given that previous studies
have reported that attention to negative emotions impairs
inhibition (Lindström and Bohlin, 2012), we expected to find
increased errors and longer reaction times, as well as larger
modulation of ERPs and time-frequency indices, in response to
pain faces, although those effects should be more pronounced
in the patients suffering from FM. We also expected to find
a significant correlation between the ERP amplitudes and the
severity of the clinical symptoms.
MATERIALS AND METHODS
Participants
A sample of 28 women with FM and 29 healthy women,
matched for age, education, laterality, and menopausal status,
were enrolled in this study. The inclusion criterion for the
FM group was a diagnosis of the disease by a health specialist
according to the ACR criteria for fibromyalgia. Exclusion criteria
were mental illness or psychiatric disorders (except anxiety and
depression). In addition, healthy controls (HCs) should not
have any chronic pain condition. For ethical reasons, patients
were not asked to withdraw prescribed medical treatments.
Demographic characteristics of the groups are shown in
Table 1.
The participants gave their written informed consent for
their participation in the study, approved by the Galician
Autonomous Committee for Research Ethics (2013/582),
and conducted in accordance with the Declaration of
Helsinki.
Measures
Clinical and sociodemographic data on the participants were
obtained via a semi-structured interview.
A series of visual-analogical scales (VAS) were created ad-hoc
to evaluate the main symptoms of FM, as well as the general
health condition of the participants. The VAS were administered
in paper-and-pencil format and consisted of 10 cm horizontal
lines in which the participants had to indicate their condition
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TABLE 1 | Demographic characteristics, and results of t-tests and χ2
comparisons between the group of fibromyalgia patients (FM) and healthy
controls (HC).
FM HC t, χ2 p
N = 28 N = 29
Age M (SD) 50.11 (9.89) 47.83 (11.06) t = 0.756 0.453
Education (%) χ² = 0.242 0.886
Primary School 33.3 37.9
High School 40.7 34.5
Higher studies 25.9 27.6
Menopausal women (%) 53.8 46.2 χ² = 0.617 0.432
Right Handed (%) 96.3 96.6 χ² = 2.01 0.367
M (SD), mean (standard deviation).
on the following variables: pain, health status, stiffness, fatigue,
mood, headache, and sleep quality. All of them were presented in
a manner that the left end indicated the best condition and the
right end the worst.
The Spanish version of the Beck Depression Inventory (BDI;
Beck et al., 1996), validated by Sanz et al. (2003) was used to assess
depressive symptoms.
The Spanish version of the Pittsburgh Sleep Quality Index
(PSQI; Jiménez-Genchi et al., 2008) was self-administered to
assess sleep quality and dysfunction during the previous month.
The Spanish version of the Pain Catastrophizing Scale was also
administered (PCS; Sullivan et al., 1995; García Campayo et al.,
2008). In addition to the total score, the 3 factors described in
the original study (rumination, magnification, and helplessness)
were taken into account.
In the Perceived Stress Scale (PSS; Cohen et al., 1994;
Remor, 2006), subjects had to indicate which of the several
statements best described how they felt during the past week,
depending on how unpredictable, uncontrollable, and overloaded
respondents find their life. It is considered a measure of the
degree to which situations in participants’ lives are appraised as
stressful.
The Spanish version of the Memory Failures of Everyday
Questionnaire (Sunderland et al., 1984; Lozoya-Delgado et al.,
2012) was also administered. The MFE-30 is a 5-point Likert
(between “never” and “very often”) questionnaire that comprises
30 items related to complaints in different cognitive domains. The
MFE-30Total score (range 0–120) was calculated as the sum of all
items. This score was ranked into four categories: 0–7, 8–35, 36–
50, and over 50, indicating optimal performance, normal, mild
deterioration, and moderate deterioration, respectively.
The above instruments were used to explore the core clinical
symptoms of fibromyalgia, including also variables, such as
catastrophism or perceived stress, which may be relevant for the
study of attentional bias toward pain-related information. Since
inhibition is an executive function, we also explored whether
the indices obtained in the Go-NoGo task were related to the
subjective cognitive complaints reported by the patients.
The handedness of participants was assessed by
administration of the Edinburgh Handedness Inventory (Oldfield,
1971).
Procedure and Stimuli
Demographic and clinical information was obtained during
the evaluation session, once participants had provided written
informed consent to take part in the study. The assessment
procedure was administered to both FM patients and HCs.
Following the initial interview and the administration of the
questionnaires, the EEG recordings took place in a poorly lit
room protected from external noise. The Go/NoGo task was
designed and presented using Psychopy software (Peirce, 2007)
on a 17-inch, 60Hz LCD monitor at a distance of 80 cm from
the subject. The stimuli consisted of micro-films, created and
validated by Simon et al. (2008). The original videos had a
duration of 1 s, but for our study, we used the last 500ms of them,
when the emotion is well-defined by the actors and is easier to
identify (see Figure 1).
The participants were instructed to fix their gaze on a cross
at the center of a computer screen during the execution of the
task. A total of 240 micro-videos of facial expressions (happy,
pain, and neutral) were presented to them in three blocks.
In each block, participants were asked to press a button with
their index finger button as quickly as possible whenever a
specific expression (neutral, happy, or pain) was displayed, and
inhibit this response when the expression displayed was different.
Each block consisted of 40 Go trials and 40 NoGo trials. The
interval between stimuli was 1.9–2.3 s. The order of the blocks
was balanced among the participants, who had a resting period
between blocks. Prior to registration, 10 practice trials were
presented with videos different from those used in the task, to
ensure that the instructions were fully understood and that facial
expressions were correctly identified.
EEG Recording and Analysis
To capture the electroencephalographic signal, we used an
actiCAP elastic cap with 32 electrodes placed according to the
10–10 International System and a Brain Vision actiCHamp
amplifier (Brain Products Inc.). The ground was placed at FPz,
and reference at FP1, which was reinstated after re-referencing.
One additional electrode was placed 1 cm below the right eye,
and vertical ocular movements weremonitored by calculating the
difference between this electrode and FP2. Electrode impedances
were kept below 10 k, and the signal was digitized at 500Hz
with an on-line bandpass filter of 0.01–200Hz, and a notch filter
at 50Hz.
EEG data were analyzed using the EEGlab 13.3 toolbox
(Delorme and Makeig, 2004). They were re-referenced to an
average reference. Data from electrodes with excessive noise
were replaced using the Spherical Spline Interpolation method.
Nine channels were interpolated for the FM group, and seven
for healthy controls. Those segments with large ocular or other
artifacts were rejected by visual inspection. Data were down-
sampled to 250Hz and digitally filtered using a 0.5Hz high-
pass FIR filter (order = 3,301) and a 30Hz low-pass FIR
filter (order = 175). Epochs of −800 to 1,800ms post-stimulus
were extracted. An independent component analysis (ICA) was
applied to eliminate artifact-related components due to EOG
or muscle activity. Linear trends were removed from epochs.
Epochs with values exceeding ± 100 µV from −600 to 1,500ms
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FIGURE 1 | Schematic example of the emotional Go/NoGo task. In each of the three blocks, one type of stimulus (pain, neutral, and happy face) was considered as
Go-stimulus. Participants were asked to press the button when a Go stimulus was presented and inhibit that action under the different stimuli (NoGo).
(excluding the ocular electrodes) were removed. There were no
group differences in the number of artifact-related ICAs removed
[mean FM = 2.96, SD = 1.4; mean HC = 2.77, SD = 1.2; t(57)
= 0.56; p = 0.58] (see the final number of epochs included for
each group and facial expression inTable 4). In addition, to avoid
group bias during data pre-processing, the researcher was blind
to the group to which each of the EEG recordings belonged.
The EEG was re-referenced using the Reference Electrode
Standardization Technique (REST) (Yao, 2001), a mathematical
procedure that recomputes the reference to a point at infinity.
REST re-referencing was computed using a MATLAB toolbox
provided by the authors of this method (Dong et al, 2017). The
baseline was corrected from −200 to 0ms. The time-frequency
decomposition was performed by calculating the inverse Fast
Fourier Transform of the multiplication of the EEG power
spectrum by the power spectrum of different complex Morlet
wavelets. Wavelets were created in 25 logarithmically-increasing
steps (from 2 to 35Hz), with 3 cycles at the lowest frequency up
to 8 at the highest frequency, also in logarithmically-increasing
steps. Event-related spectral perturbation was then normalized to
decibel (dB) transformation, using the mean power from −400
to −150ms as the baseline. We analyzed power values of theta
over midfrontal areas (FC1 and FC2), the location where these
oscillations are frequently observed (Cavanagh and Frank, 2014).
Given the visual nature of the stimuli, we also measured delta
and theta bands over posterior visual areas (O1 and O2). We
first averaged the spectrograms of all conditions in both groups
together and then we selected the time-frequency windows where
the power modulation was maximum, this window selection
method is independent of group/condition differences (Cohen
and van Gaal, 2013). The power peak for midfrontal theta was
around 3.5Hz, while posterior theta showed its peak at around
5Hz. We found an increase in the power of slower oscillations
(2–4Hz) over posterior areas. Given that they can be useful for
acquiring insight into the processing of dynamic visual stimuli,
we also compared the posterior delta power between groups and
conditions (see Figure 2).
We also measured the mean amplitude of P3 at the Cz
electrode in a window from 350 to 600ms, and the mean
amplitude of N2 at the Fz electrode in a window from 250 to
340ms only in NoGo trials. The selection of electrodes was based
on previous reports (Falkenstein et al., 1999), while the time
windows were selected based on the time when these components
showed their greatest amplitude.
Statistical Analysis
Means and standard deviations were used to describe the
quantitative variables, while absolute frequencies and percentages
were used for the qualitative measures. Differences between FM
and HC groups in clinical and sociodemographic variables were
analyzed using Student’s t-test or Chi-square test, depending on
the type of variable considered. Repeated measures ANOVAs
with Group (2 levels: FM, HC) as between-subject factor, and
Facial Expression (3 levels: happy, pain, neutral) as within-subject
factor, were performed for behavioral indices (reaction times
and hits), for midfrontal theta, posterior theta, and posterior
delta power, and for the amplitude values of P3 and N2.
The Bonferroni correction method was applied for post-hoc
multiple comparisons. Associations between ERPs amplitudes
and clinical variables for FM patients were quantified using
Pearson correlations. To overcome the problem of multiple
comparisons in the correlations, the False Discovery Rate
(FDR) correction—using the “fdr” function of EEGlab—was
applied.
All statistical analyses were performed using SPSS version 20
(Statistics, 2013).
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FIGURE 2 | Time-frequency decomposition of the EEG to pain, neutral, and happy faces obtained from patients with FM and healthy controls in NoGo trials. Upper
row: mid-frontal theta (FC1/FC2); lower row: posterior alpha and theta (O1/O2). The spectrograms averaged across conditions and groups are shown in the left




There were no significant differences between the FM and HC
groups in terms of age, education, menopausal status, or laterality
(Table 1).
Regarding clinical variables, the comparisons between the
FM and HCs were statistically significant for all the scales and
subscales analyzed (Table 2). Concerning VAS, the highest scores
for the patients’ group were on the pain, stiffness, fatigue, and
sleep quality scales, the core symptoms of fibromyalgia. With
respect to the Pain Catastrophizing Scale (PCS), FM patients
obtained an average score of 23.72 (SD = 15.26) and the control
group an average of 11.00 (SD= 8.93). It should be noted that the
groups differed in all the 3 factors that comprise the scale. As for
the Beck Depression Inventory (BDI), we also found significantly
higher means for the FM group (mean= 20.16) compared to the
control group (mean = 10.17). Patients also showed worse sleep
quality in the Pittsburgh Sleep Quality Index (PSQI) than healthy
controls (13.04 vs. 5.75), broader subjective cognitive complaints
in the Memory Failures of Everyday Questionnaire (MFE-30)
(50.95 vs. 26.16) and higher stress levels in the Perceived Stress
Scale (PSS) compared to the control group (31.78 vs. 21.71).
Behavioral Data
The behavioral data obtained by FM patients and HCs in the Go
and NoGo trials for happy, pain, and neutral stimuli are shown
in Table 3.
There was a significant effect of Facial Expression for the
reaction times in Go trials [F(2, 114) = 18.34; p < 0.001; ηp
2
=
0.243; Pain = 650 ± 118 ms; Neutral = 617 ± 123; Happy =
590 ± 90], as well as for the percentage of correct answers in
both the Go [F(2, 114) = 46.59; p < 0.001; ηp
2
= 0.450; Pain =
84.7 ± 9.7%; Neutral = 95.1 ± 77.8; Happy = 96.7 ± 4.9] and
NoGo [F(2, 114) = 40.40; p < 0.001; ηp
2
= 0.415; Pain = 89.7
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TABLE 2 | Clinical variables of FM patients and healthy controls (HC).
FM HC t p
VAS M (SD)
Pain 6.61 (1.7) 3.12 (3.6) 4.433 <0.001
Health 5.92 (2.2) 3.45 (3.1) 3.271 0.002
Stiffness 7.98 (2.1) 2.30 (2.8) 8.122 <0.001
Fatigue 7.48 (1.8) 3.14 (2.5) 6.996 <0.001
Mood 5.45 (3.0) 3.12 (2.4) 2.913 0.006
Headache 4.85 (3.1) 1.68 (2.5) 3.966 <0.001
Sleep quality 7.46 (2.6) 3.56 (3.0) 4.822 <0.001
BDI M (SD)
Total score 20.16 (10.4) 10.17 (6.0) 4.029 <0.001
PSQI M (SD)
Total score 13.04 (4.9) 5.75 (3.8) 5.484 <0.001
PCS M (SD)
Rumiation 7.50 (5.2) 4.04 (3.4) 2.826 0.007
Magnification 5.00 (3.7) 2.84 (2.4) 2.453 0.018
Helplessness 10.92 (7.1) 4.11 (4.3) 4.168 <0.001
Total score 23.72 (15.3) 11 (8.9) 3.648 0.001
PSS M (SD)
Total score 31.78 (11.1) 21.71 (8.3) 2.923 0.006
MFE-30 M (SD)
Total score 50.95 (23.87) 26.16 (13.38) 4.012 <0.001
FM, fibromyalgia; HC, healthy controls; t, Student’s t; M (SD), mean (standard deviation);
VAS, Visual Analogue Scale; BDI, Beck Depression Inventory; PSQI, Pittsburgh Sleep
Quality Index; PCS, Pain Catastrophizing Scale; PSS, Perceived Stress Scale; MFE-30,
Memory Failures of Everyday Questionnaire.
TABLE 3 | Behavioral data (reaction times in milliseconds [RT] and percentage of
hits) in the Go and NoGo trials for pain, neutral, and happy facial expressions in
fibromyalgia (FM) patients and healthy controls (HC).
Pain Neutral Happy
FM HC FM HC FM HC
Go
RT 641 (97) 659 (134) 622 (130) 612 (119) 595 (83) 586 (98)
% hits 87.3 (8.4) 82.4 (10.4) 95.2 (7.9) 95.0 (7.8) 96.5 (5.1) 96.9 (4.9)
NoGo
% hits 88.6 (7.3) 90.6 (5.6) 96.7 (4.3) 98.7 (2.8) 93.6 (8.9) 94.1 (5.8)
± 6.5%; Neutral = 97.7 ± 3.7; Happy = 93.9 ± 7.4] trials. A
posteriori contrasts showed that, in the Go trials, faces of pain
were associated with slower reaction times than neutral (p <
0.001) and happy (p < 0.001) faces and, moreover, they were
also associated with more errors than neutral (p < 0.001) and
happy (p < 0.001) faces in both groups. Happy faces showed the
fastest reaction times and the largest hit percentages. There was
no significant interaction between emotion and group. As for
the NoGo trials, pain faces were also associated with the worse
hit percentages in both groups (p < 0.001). In this case, when it
comes to inhibiting the response, neutral stimuli were associated
with the best performance.
Electrophysiological Data
For time-frequency data (see Figure 2), we measured midfrontal
theta oscillations (2.5–6Hz) over FC1 and FC2 and from 100 to
600ms. An effect of Facial Expression was found for theta power
[F(2, 114) = 6.61; p = 0.002; ηp
2
= 0.104; Pain = 3.06 ± 1.36 dB;
Neutral = 2.72 ± 1.20; Happy = 2.63 ± 1.15), with differences
between pain and neutral (p= 0.005) and pain and happy faces (p
= 0.017) after post-hoc comparisons. No significant Group effect
[F(1, 57) = 0.05; p = 0.94] or interaction [F(2, 114) = 2.41; p =
0.094] were observed.
Posterior delta activity (2–4Hz)—measured over O1 and O2
electrodes and from 100 to 600 ms—showed a main effect of
Facial expression [F(2, 114) = 4.21; p = 0.017; ηp
2
= 0.069;
Pain = 2.34 ± 1.42; Neutral = 1.94 ± 1.31; Happy = 1.81 ±
1.55], with significant differences only between pain and neutral
conditions (p = 0.040) in pairwise comparisons. No Group
difference [F(1, 57) = 0.03; p = 0.85] or interaction [F(2, 114) =
0.05; p= 0.95] were found significant.
Posterior theta oscillations (4–7Hz)—measured over O1 and
O2 from 100 to 400 ms—also showed an effect of Facial
expression [F(2, 114) = 4.85; p= 0.010; ηp
2
= 0.08; Pain= 2.99±
1.66; Neutral = 2.59 ± 1.70; Happy = 2.59 ± 1.53]. Again, post-
hoc comparisons showed differences between pain and neutral (p
= 0.043) and pain and happy conditions (p = 0.009), with no
significant Group effect [F(1, 57) = 0.05; p = 0.83] nor Group ×
Facial expression interaction [F(2, 114) = 0.65; p= 0.52].
Concerning ERPs, Table 4 shows the average amplitude (µV)
for the two ERPs components analyzed.
For P3 amplitude, the results showed a significant effect of
Facial Expression [F(2, 114) = 3.55; p = 0.032; ηp
2
= 0.059].
Subsequent contrasts showed significantly larger P3 amplitude
for pain (mean = 3.41 ± 3.09 µV) than for happy faces (mean
= 2.89 ± 2.77 µV) (p = 0.027). No significant Group effect was
found significant.
For N2, the ANOVA showed a significant Facial Expression×
Group interaction for the amplitude of this component [F(2, 114)
= 3.42; p = 0.036; ηp
2
= 0.057]. A posteriori contrasts showed
significant differences between pain (mean = −5.02 ± 0.66 µV)
and neutral faces (mean = −4.10 ± 5.88 µV), (p = 0.001); and
between pain and happy faces (mean = −4.18 ± 0.59 µV), (p =
0.005), only for the control group. For the patients’ group, there
was no difference in the amplitude of N2 among any emotional
category. The waveforms obtained in the NoGo trials at Fz and
Cz electrodes for all the stimuli are shown in Figure 3.
To clarify whether there is a relationship between the
amplitude of the N2 and P3 components for pain faces and the
clinical variables, Pearson correlations were performed with the
FM patients’ data. Two of the correlations showed a p-value <
0.05: the amplitude of N2 and the quality of sleep measured
with the PSQI (r = 0.516; p = 0.007), and the amplitude of
P3 and the level of pain assessed by the VAS (r = −0.466; p
= 0.016). However, none of these 2 correlations survived the
FDR correction. No other correlation between ERPs and clinical
indices was found significant.
DISCUSSION
The objective of this study was to test whether patients with
fibromyalgia (FM) show a larger interference of attention toward
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TABLE 4 | Number of EEG epochs and average amplitudes in µV (SD in parentheses) for the P3 and N2 components (NoGo trials) in patients with FM and healthy control
(HC) subjects for each type of facial expression.
Pain Neutral Happy
FM HC FM HC FM HC
Number of EEG epochs 32.5 (2.0) 32.7 (1.5) 34.20 (1.9) 34.5 (1.7) 32.8 (2.5) 32.1 (2.0)
P3 NoGo 3.44 (2.9) 3.37 (3.3) 3.40 (2.4) 2.94 (2.8) 2.60 (2.5) 3.16 (3.0)
N2 NoGo −4.52 (4.1) −5.02 (3.2) −4.40 (3.7) −4.10 (2.9) −4.69 (3.8) −4.18 (2.8)
FIGURE 3 | ERPs grand-averages (at Fz and Cz electrodes) for pain, neutral, and happy NoGo trials in patients with fibromyalgia (FM) and healthy controls (HC).
Shaded areas show the time windows selected for statistical comparisons. Topographical distribution of brain electrical activity (average of the selected time windows)
for each group and condition are shown on the right-hand side.
pain-related stimuli over inhibitory control. We recorded brain
electrical activity during a Go/NoGo emotional task, in which the
participants had to respond or withhold the response to dynamic
images of faces with different expressions. Given the dynamic
nature of the stimuli, we performed EEG time-frequency analyses
(midfrontal theta and posterior delta and theta) and also obtained
the ERPs N2 and P3 in NoGo trials.
First, our data support that attention to pain faces interferes
with response inhibition. Behaviorally, pain expressions were
associated with a higher percentage of errors and slower reaction
times. This result suggests that pain-related stimuli are more
conflicting and may engage more attentional resources to their
processing, resulting in longer reaction times. Nevertheless, this
effect was not different in patients and controls.
Pearce and Morley (1989) were pioneers in the study of
attentional bias (AB) in chronic pain. Using an emotional Stroop
task, they found that FM patients had longer reaction times in
naming the color of words related to their pain condition than
to those with neutral or emotionally negative semantic content.
This was taken as evidence that chronic pain patients show AB
toward pain-related information, as revealed by their focus on a
dimension irrelevant to the task—facial expression—, causing a
slowdown response to the color of the word (Pearce and Morley,
1989). Nevertheless, literature results are far from conclusive.
The study of AB in patients with FM has also yielded
contradictory findings. González et al (2010) used an emotional
Stroop task and explored the possible mediator role of anxiety in
AB. Paradoxically, they found that FM patients were significantly
slower in the color denomination of neutral words while
showed a non-significant tendency to be slower in symptom-
related and negative valence words. These effects were not
mediated by anxiety, but by the degree of perceived displeasure
associated with negative stimuli. In contrast, Duschek et al.
(2014) found a strong emotional interference in FM patients
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in relation to healthy subjects, manifested as a greater response
delay in naming the color of negative words compared to
neutral adjectives (Duschek et al., 2014). They suggested that,
in FM patients, negative information recruits a disproportionate
amount of cognitive resources, thereby slowing concurrent
processes.
Although we used a different strategy—to analyze the
influence of attention to pain over inhibitory control—our
behavioral results are in line with the conclusions of the meta-
analysis conducted by Crombez et al. (2013) that the AB toward
negative emotional information is similar in chronic pain and
healthy subjects. Also, behavioral data agree with the results of
Glass et al. (2011), who observed the same RTs and accuracy
in FM patients during a simple Go/NoGo task. Since previous
studies have suggested greater effectiveness of images to represent
emotions—as compared to words—(Crombez et al., 2000, 2013;
Van Damme et al., 2010), in this paper we used images and, to
make themmore realistic and with a greater impact, we presented
them dynamically. Despite this choice, we have not been able to
observe a pattern of response that confirms larger interference of
pain stimuli over inhibitory control in patients than in healthy
controls.
To better know the temporal characteristics of neural
activation involved in response inhibition, we recorded EEG
during the performance of the task and analyzed it with two
different methodologies. Since the ERPs components may be
reflecting overlapping theta and delta activity (Harper et al.,
2014), and given the dynamic nature of our stimuli, we
applied time-frequency decomposition to the EEG. We analyzed
midfrontal theta, and posterior delta and theta bands, and
found that all of them were significantly larger for pain faces,
but no between-group differences emerged. Concerning ERPs,
and also in parallel with the time-frequency and behavioral
results, NoGo-P3 was larger when pain faces were presented,
but the effect was similar for the patients and healthy controls.
In this vein, our results also contrast with previous studies.
In 2013, Mercado and colleagues using a Stroop emotional
paradigm found larger amplitudes of the P450 component in
the patients when processing symptom-related stimuli compared
to the rest of the stimuli. This was interpreted as an increase
in prefrontal neuronal activity when processing information
related to FM symptoms. As they did not find between-groups
differences in behavioral outcomes, they hypothesized that an
increased P450 component could be reflecting the activation of
a compensation mechanism to keep cognitive task performance
through additional cognitive inhibitory resources (Mercado et al.,
2013). González-Roldán et al. (2013) also found that FM patients
had larger N100 amplitudes to facial expressions of pain and
anger than happiness. Unlike previous studies, which used
pure and simple attentional tasks, we used a more demanding
paradigm where subjects had to identify the facial expression and
then prepare or withhold their motor response. Even so, and
using stimuli directly related to FM symptoms such as pain, we
were not able to identify differences in brain activity related to
response inhibition. The fact that time-frequency analyses and
P3 data are fully consistent adds robustness to the main finding
of this paper, which does not confirm that patients have difficulty
disengaging their attention from pain-related information while
performing an inhibition task.
Our results are in line with a recent study by Sitges et al. (2018)
who compared FMpatients with pain-free subjects in a Go/NoGo
task using pain, happy and neutral faces and did not find group
differences in N200 and P300 amplitudes, what was interpreted
as a lack of significant impairment in response inhibition due
to pain. Nevertheless, they contradict Glass et al. (2011) report
on decreased activation in cortical structures of the inhibition
network in FM patients, which was interpreted by the authors as
a consequence of neural resources being used for pain processing.
The only significant electrophysiological difference between
the groups is related to the amplitude of N2, for which we found
an interaction of group with the type of facial expression. Only
for healthy participants, N2 showed differences between pain and
both neutral and happy faces. The N2 component obtained in the
NoGo trials has been linked to inhibitory processes, and more
recently, to conflict detection (Falkenstein et al., 1999; Donkers
and Van Boxtel, 2004). Therefore, the data seem to indicate that,
in healthy controls, the processing of facial expressions of pain
may produce more conflict; whereas in patients, who are more
familiarized to pain and may require fewer attentional resources
to identify it, the conflict would be lesser. This would explain the
lack of N2 amplitude modulation in the presence of pain faces in
the patients.
Alternatively, this result could also indicate a delay in
emotional processing in the patients, as about 300ms post-
stimulus they have not yet differentiated the emotional content.
However, the lack of a significant difference in reaction times
between patients and healthy controls does not seem to support
this explanation. Finally, it could also be interpreted as less
emotional reactivity in patients with fibromyalgia. In this
regard, there are studies that corroborate that alexithymia, a
personality construct characterized by difficulty in identifying
and communicating feelings (Taylor, 1984), may play a role in
the maintenance or exacerbation of fibromyalgia symptoms (van
Middendorp et al., 2008; Huber et al., 2009).
To elucidate the relationship between the ERPs obtained in
the presence of painful faces and clinical variables, we performed
a correlational analysis for the FM group. Although a priori the
data suggested two significant correlations, these did not survive
the FDR correction. Contrary to what might be expected, we
found no correlation between variables such as catastrophism or
depression and the ERPs. In this vein, Sitges et al. (2018) did not
find significant differences between FM patients with low or high
depression on N2 and P3 amplitudes.
Our study adds to a growing body of research that has
failed to find evidence of an attentional bias toward pain-related
stimuli in patients with fibromyalgia other than the present in
healthy subjects. More sensitive paradigms may be necessary to
elicit the response bias toward pain stimuli. Also, and despite
using dynamic images instead of written words, our stimuli may
not have had enough impact, and might not have interfered
with emotional processing. Perhaps the impact would have been
greater if the images referred to pain experienced by the subject
himself, and not to the pain of others since some authors suggest
that biases in information processing are increasing and may
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even be dependent on self-referential coding (Pincus et al.,
1998). However, research on pain empathy seems to support the
ecological validity and impact of the stimuli used: subjective pain
perception has been shown to be enhanced by the observation of
other persons in pain (Godinho et al., 2008), and recent imaging
studies have shown overlapping activation patterns when subjects
feel their own emotions and observe the same emotions in others
(Ochsner and Gross, 2008).
Attention influences subjective pain (Miron et al., 1989) and
is accompanied by activity changes in pain-related brain areas
(Godinho et al., 2008). It is important for future research to
fully explore the role attentional bias plays in the causation and
maintenance of chronic pain diseases like fibromyalgia, and the
potential consequences AB may have upon the patients’ quality
of life (Schoth et al., 2012). AB to pain-related information
may initially be adaptive, allowing us to escape or avoid pain.
However, if an attentional bias persists even when pain is
inevitable—as in the case of chronic pain—it can only exacerbate
pain, disability, and distress (Van Ryckeghem et al., 2013),
and enhance symptoms including dyscognition, anxiety, and
depression. Hence, AB remains a potentially important factor in
the development of chronic pain and fibromyalgia, and a relevant
area of focus when developing treatment strategies.
As limitations of the present study, we may underscore
the fact that we used equiprobable Go and NoGo trials.
Although this is rather frequent in the literature, Wessel (2018)
found that slow-paced and equiprobable Go/NoGo tasks were
associated with a reduction in frontocentral P3 amplitude. Thus,
our task might have not been enough sensitive to capture
differences between groups. Although conducting ERP analyses
with dynamic stimuli might be questionable, other ERPs studies
have also used dynamic facial expressions and found that they
even produced greater amplitudes than the static ones (Recio
et al., 2011). Another limitation is related to the medication
intake monitoring. Due to the slight efficacy of pharmacological
treatment, FM patients tend to be polymedicated and subjected
to continuous drugs modifications. Participants were asked
not to take more medicines than necessary but, for ethical
reasons, the prescribed treatment was not withdrawn. Finally,
and considering the small effect sizes found, we must bear in
mind that “no evidence of effect” does not imply “evidence of
no effect.” Thus, larger sample sizes are needed to discard that
patients with chronic pain do not exhibit attentional bias.
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